{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:49:50Z","timestamp":1792687790568,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.eururo.2022.03.027","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:33:30Z","timestamp":1649118810000},"page":"182-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria"],"prefix":"10.1016","volume":"82","author":[{"given":"Bhavan P.","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Luis Dominguez Escrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teele","family":"Kuusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otakar","family":"Capoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman M.","family":"Bruins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe D.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Santesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas W.G.","family":"van Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hugh Mostafid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imran Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2022.03.027_b0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-5347(17)40763-4","article-title":"The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis","volume":"141","author":"Mariani","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eururo.2018.03.008","article-title":"Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients","volume":"74","author":"Tan","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bju.14016","article-title":"Guideline of guidelines: asymptomatic microscopic haematuria","volume":"121","author":"Linder","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.03.027_b0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamainternmed.2017.0739","article-title":"Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria","volume":"177","author":"Halpern","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2022.03.027_b0025","series-title":"Suspected cancer: recognition and referral","author":"National Collaborating Centre for Cancer","year":"2015"},{"key":"10.1016\/j.eururo.2022.03.027_b0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2022.03.027_b0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2022.03.027_b0045","unstructured":"The Cochrane Collaboration. Cochrane Prognosis Methods Group. http:\/\/prognosismethods.cochrane.org\/."},{"key":"10.1016\/j.eururo.2022.03.027_b0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2022.03.027_b0055","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.eururo.2022.03.027_b0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-5347(05)67916-5","article-title":"A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0065","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7196\/SAMJ.2019.v109i11.13827","article-title":"One-stop haematuria clinic: first experience in South Africa","volume":"109","author":"Sinha","year":"2019","journal-title":"South Afr Med J"},{"key":"10.1016\/j.eururo.2022.03.027_b0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bjmsu.2010.04.002","article-title":"Three-year outcomes of a visible haematuria clinic\u2014no initial role for urine cytology?","volume":"3","author":"Munro","year":"2010","journal-title":"Br J Med Surg Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejrad.2009.10.027","article-title":"The diagnostic efficiency of ultrasound guided imaging algorithm in evaluation of patients with hematuria","volume":"79","author":"Unsal","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.eururo.2022.03.027_b0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2010.09521.x","article-title":"Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up","volume":"107","author":"Edwards","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.03.027_b0085","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.juro.2010.12.093","article-title":"Association of hematuria on microscopic urinalysis and risk of urinary tract cancer","volume":"185","author":"Jung","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1089\/end.2011.0225","article-title":"Computed tomography-urography for upper urinary tract imaging: Is it required for all patients who present with hematuria?","volume":"25","author":"Cauberg","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2022.03.027_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1117-1936.170293","article-title":"Gross haematuria among adult Nigerians: current trend","volume":"18","author":"Ogunjimi","year":"2011","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.eururo.2022.03.027_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2011.08.073","article-title":"Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0105","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2012.381","article-title":"Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine","volume":"107","author":"Saeb-Parsy","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2022.03.027_b0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.juro.2012.05.003","article-title":"A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria","volume":"188","author":"O\u2019Sullivan","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0115","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.mayocp.2012.04.013","article-title":"A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria","volume":"87","author":"Karnes","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eururo.2022.03.027_b0120","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.7314\/APJCP.2013.14.11.6327","article-title":"Stratifying patients with haematuria into high or low risk groups for bladder cancer: a novel clinical scoring system","volume":"14","author":"Hee","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.eururo.2022.03.027_b0125","doi-asserted-by":"crossref","first-page":"e77657","DOI":"10.1371\/journal.pone.0077657","article-title":"The use of molecular analyses in voided urine for the assessment of patients with hematuria","volume":"8","author":"Beukers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2022.03.027_b0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bjmsu.2012.06.007","article-title":"The evaluation of CT urography in the haematuria clinic","volume":"6","author":"Bromage","year":"2013","journal-title":"J Clin Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0135","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.juro.2012.10.022","article-title":"Routine urine cytology has no role in hematuria investigations","volume":"189","author":"Mishriki","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2013.02.036","article-title":"Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers","volume":"64","author":"Bangma","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mayocp.2012.10.004","article-title":"Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria","volume":"88","author":"Loo","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eururo.2022.03.027_b0150","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.7314\/APJCP.2014.15.16.6819","article-title":"External validation of a clinical scoring system for hematuria","volume":"15","author":"Lee","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.eururo.2022.03.027_b0155","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.juro.2014.05.087","article-title":"Prospective external validation of a bladder cancer detection model","volume":"192","author":"Lotan","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urolonc.2012.07.001","article-title":"What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up","volume":"32","author":"Buteau","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2022.03.027_b0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/ans.12742","article-title":"Streamlining the assessment of haematuria: 3-year outcomes of a dedicated haematuria clinic","volume":"85","author":"Sapre","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.eururo.2022.03.027_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12894-015-0018-5","article-title":"A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma","volume":"15","author":"Kavalieris","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/2051415814548913","article-title":"Quantifying the risk of malignancy in patients with visible haematuria presenting to the emergency department","volume":"8","author":"Gan","year":"2015","journal-title":"J Clin Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0180","first-page":"253","article-title":"Flexible cystoscopy a valuable diagnostic tool for lower urinary tract pathology","volume":"65","author":"Sajid","year":"2015","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.eururo.2022.03.027_b0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/iju.12697","article-title":"Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population","volume":"22","author":"Kang","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0190","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.eururo.2016.06.035","article-title":"A prospective blinded evaluation of urine-DNA testing for detection of urothelial bladder carcinoma in patients with gross hematuria","volume":"70","author":"Dahmcke","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/OGX.0000000000000438","article-title":"Evaluation of microscopic hematuria and risk of urologic cancer in female patients","volume":"72","author":"Lippmann","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.eururo.2022.03.027_b0200","doi-asserted-by":"crossref","first-page":"e12982","DOI":"10.1111\/ijcp.12982","article-title":"Haematuria work-up in general care\u2014a German observational study","volume":"71","author":"Eisenhardt","year":"2017","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2022.03.027_b0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/21681805.2017.1310759","article-title":"Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark","volume":"51","author":"Elmussareh","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.juro.2017.06.083","article-title":"Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race and risk factors for bladder cancer","volume":"198","author":"Ark","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/21681805.2017.1334699","article-title":"Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract","volume":"51","author":"Ordell Sundelin","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.urolonc.2017.09.011","article-title":"Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria","volume":"36","author":"Samson","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2022.03.027_b0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.urolonc.2017.11.004","article-title":"Diagnostic evaluation of patients presenting with hematuria: an electronic health record-based study","volume":"36","author":"Richards","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2022.03.027_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/BLC-190221","article-title":"Evaluation of hematuria in a large public health care system","volume":"5","author":"Ghandour","year":"2019","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.eururo.2022.03.027_b0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5489\/cuaj.5809","article-title":"Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: turning urine into gold","volume":"13","author":"Assmus","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2022.03.027_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2019.07.009","article-title":"Evaluation of asymptomatic microscopic hematuria by renal ultrasound to detect upper tract malignancy: a 20-year experience in a community hospital","volume":"133","author":"Smith","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.03.027_b0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2019.01.011","article-title":"The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria","volume":"126","author":"Gonzalez","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.03.027_b0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.urolonc.2019.01.007","article-title":"Disparities in the diagnostic evaluation of microhematuria and implications for the detection of urologic malignancy","volume":"37","author":"Matulewicz","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2022.03.027_b0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.06.006","article-title":"A novel, non-invasive test enabling bladder cancer detection in urine sediment of patients presenting with haematuria\u2014a prospective multicentre performance evaluation of ADXBLADDER","volume":"3","author":"Dudderidge","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2022.03.027_b0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00345-020-03171-6","article-title":"Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria","volume":"39","author":"Fankhauser","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2022.03.027_b0265","first-page":"203","article-title":"Urinary tract ultrasonography in the evaluation of haematuria\u2014a report of over 1,000 cases","volume":"84","author":"Datta","year":"2002","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.eururo.2022.03.027_b0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bju.15483","article-title":"The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer \u2013 a multicentre observational study","volume":"128","author":"Khadhouri","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.03.027_b0275","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamainternmed.2019.2280","article-title":"Comparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuria","volume":"179","author":"Georgieva","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2022.03.027_b0280","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1470-2045(13)70588-6","article-title":"Preferences for cancer investigation: a vignette-based study of primary-care attendees","volume":"15","author":"Banks","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822017985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822017985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:11:57Z","timestamp":1759583517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283822017985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0302283822017985"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2022.03.027","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}